Sean Parker, neoantigens and the Cancer Research Institute
Old and new research worlds collided on Thursday through the partnership of the decades-old Cancer Research Institute (CRI) and The Parker Institute for Cancer Immunotherapy, created by tech billionaire Sean Parker in April 2016.